Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment-Reference-Cited by-同舟云学术

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

Published:2019-09-14 Issue:18 Volume:40 Page:5424-5442
ISSN:1065-9471
Container-title:Human Brain Mapping
language:en
Short-container-title:Hum Brain Mapp

Author:

Chandra Avinash¹^ORCID,Valkimadi Polytimi‐Eleni¹,Pagano Gennaro¹,Cousins Oliver¹,Dervenoulas George¹,Politis Marios¹,

Affiliation:

1. Neurodegeneration Imaging Group (NIG), Institute of Psychiatry, Psychology and Neuroscience (IoPPN) King's College London (KCL) London UK

Funder

Alzheimer's Disease Neuroimaging Initiative

Alzheimer’s Research UK

National Institute for Health Research

Avid Radiopharmaceuticals

Medical Research Council Canada

CHDI Foundation

Foundation for the National Institutes of Health

Canadian Institutes of Health Research

Takeda Pharmaceutical Company

Servier

Pfizer

Novartis Pharmaceuticals Corporation

GE Healthcare

Genentech

F. Hoffmann-La Roche

Eli Lilly and Company

Eisai

Bristol-Myers Squibb

Biogen

BioClinica

Alzheimer's Drug Discovery Foundation

Alzheimer's Association

AbbVie

National Institute of Biomedical Imaging and Bioengineering

National Institute on Aging

U.S. Department of Defense

National Institutes of Health

Publisher

Wiley

Subject

Clinical Neurology,Neurology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology,Anatomy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hbm.24782

Reference157 articles.

1. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue

2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Amyloid load and cerebral atrophy in Alzheimer's disease: An11C-PIB positron emission tomography study

4. Prediction of Amyloid-β Pathology in Amnestic Mild Cognitive Impairment with Neuropsychological Tests

5. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application value of Rs-fMRI-based machine learning models for differentiating mild cognitive impairment from Alzheimer's disease: a systematic review and meta-analysis;Neurological Sciences;2024-09-03

2. EEG Changes in Patients with Alzheimer’s Disease;Neuroscience and Behavioral Physiology;2024-07

3. Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review;IBRO Neuroscience Reports;2024-06

4. PET-based brain molecular connectivity in neurodegenerative disease;Current Opinion in Neurology;2024-05-30

5. Neuroinflammation in dementia: A meta-analysis of PET imaging studies;Medicine;2024-05-03